NAFDAC Orders Withdrawal of Unsafe Malaria Suspension

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a directive for the immediate withdrawal of multi-dose artemether-lumefantrine dry powder oral suspension from circulation across Nigeria. This decision follows a public alert (No. 01 2025) issued on February 27, 2025, after surveillance reports indicated that the product was still being dispensed to patients.

NAFDAC emphasized that the multi-dose malaria oral suspension is no longer approved for registration or importation into Nigeria. The agency has instructed zonal directors and state coordinators to monitor and remove the affected products from the market.

Importers, distributors, and healthcare professionals have been advised to cease the importation and sale of this multi-dose anti-malarial oral suspension product. The agency's action is part of ongoing efforts to curb the circulation of unsafe and substandard medical products in Nigeria, as the continued presence of this product poses serious health risks to patients.